Health
Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine – News-Medical.Net
A group of scientists from Israel sought to evaluate the long-term effectiveness of the BioNTech/Pfizer mRNA BNT162b2 vaccine….
Several studies have shown the effectiveness of the BioNTech/Pfizer messenger ribonucleic acid (mRNA) BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Two doses of the vaccine have been shown to provide a short-term effect.
…
Continue Reading
-
Business21 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business20 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News17 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business17 hours ago1 ASX dividend stock down 43% I’d buy right now